PCI provides fully audited, in-house laboratories in both our European and North America locations offering a range of analytical services to support clients in the development and commercialization of new medicines.
Staffed with expertly qualified analytical chemists, trained and accredited in the most comprehensive laboratory standards, we provide a complete range of resources and responsive services at each stage of the product lifecycle across a wide variety of dosage forms.
Our state-of-the-art facilities feature best-in-class and fully GMP and ICH compliant equipment enabling our teams to perform simple ID testing and analytical method transfers, through method development and validation, to EU product release and ICH stability testing, ensuring data reliability and regulatory compliance.
Our facilities also include HEPA filtered air handling systems for the analysis of cytotoxic, teratogenic and uncharacterized products, a darkroom for the analysis of light sensitive products, and the capabilities to work with Schedule II-IV controlled substances.
Anaytical services are offered on a stand-alone basis or in conjunction with our clinical, commercial and QP services to facilitate a seamless transmission through the drug development cycle.